Here we firstsystematically perceive the O-GlcNAcylation, OGT,and OGA levels in human CCA samples, then perturb the CCA cell lineswith Click-iG to profile O-GlcNAcome with glycancomposition and glycosylation site resolution. The gene discussed is OGT; the disease is cholangiocarcinoma.